Trials / Completed
CompletedNCT04013191
A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants
An Open-Label, Parallel-Group, Pharmacokinetic, Safety and Tolerability Study of Single and Multiple Oral Administrations of Padsevonil in Adult and Elderly Study Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- UCB Biopharma S.P.R.L. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the plasma pharmacokinetic of padsevonil in adult and elderly study participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Padsevonil | Padsevonil will be administered in predefined dosages. |
Timeline
- Start date
- 2019-07-09
- Primary completion
- 2019-10-03
- Completion
- 2019-10-03
- First posted
- 2019-07-09
- Last updated
- 2021-06-30
- Results posted
- 2021-06-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04013191. Inclusion in this directory is not an endorsement.